• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; TIMER, CLOT, AUTOMATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; TIMER, CLOT, AUTOMATED Back to Search Results
Model Number 305
Device Problem Insufficient Information (3190)
Patient Problems Stroke/CVA (1770); Death (1802); Non specific EKG/ECG Changes (1817); Hemorrhage/Bleeding (1888); Myocardial Infarction (1969); Transient Ischemic Attack (2109)
Event Date 09/05/2012
Event Type  Injury  
Manufacturer Narrative
(b)(4).Title: transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score¿matched case-control study citation: am heart j.2012 dec;164(6):910-7 (doi: 10.1016/j.Ahj.2012.09.005) authors: azeem latib, mb chb, francesco maisano, md, letizia bertoldi, md, andrea giacomini, md, joanne shannon, md, micaela cioni, md, alfonso ielasi, md, filippo figini, md, kensuke tagaki, md, annalisa franco, md, remo daniel covello, md, antonio grimaldi, md, pietro spagnolo, md, gill louise buchannan, md, mauro carlino, md, alaide chieffo, md, matteo montorfano, md, ottavio alfieri, md, and antonio colombo, md date accepted by publisher used for event date.
 
Event Description
Medtronic received information via literature review of a study performed to compare outcomes after transcatheter aortic valve replacement (tavr) and surgical aortic valve replacement (savr) in patients with severe symptomatic aortic stenosis.The study population included 405 patients (mean age 79.8 years), 276 of which underwent tavr from november 2007 thru february 2011 and 129 of which un derwent savr from august 2003 thru june 2008.A propensity score matching based on clinical characteristics and surgical risk scores was then utilized to compare 222 patients (111 from each the tavr and savr groups).Of the 111 tavr patients, 41 received a medtronic transcatheter bioprosthetic valve (serial numbers not reported).Of the 111 savr patients, 26 received a medtronic surgical bioprosthetic valve (serial numbers not reported).Among all 222 matched patients, 16 total cardiovascular deaths (7 tavr; 9 savr) occurred within one year follow-up.No deaths were directly attributed to medtronic products.Among all 222 matched patients, peri-procedural and in-hospital adverse events included: 150 life-threatening/major bleeding complications (68 tavr; 82 savr), 38 acute kidney injury (9 tavr; 29 savr), 16 permanent pacemaker (13 tavr; 3 savr), 16 major vascular complications (tavr only), 4 repeated intervention for unspecified valve-related malfunction (3 tavr; 1 savr), and 2 surgical interventions (savr only).Adverse events up to one year post-implant included: 15 stroke/transient ischemic attack (5 tavr; 10 savr), and 2 myocardial infarction (savr only).The authors noted a significantly higher incidence of permanent pacemaker required for medtronic transcatheter bioprosthetic valves (10/41) as compared with non-medtronic transcatheter bioprosthetic valves (3/70).Apart from this statement, no other adverse events were directly attributed to medtronic products.No additional adverse patient effects were reported.Additional information has been requested.
 
Manufacturer Narrative
No device was returned and no unique device identifier (serial/lot) numbers were provided.Without unique device identifier information a review of the device history record could not be performed and root cause could not be determined.
 
Event Description
Requests for additional information provided no further details.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
TIMER, CLOT, AUTOMATED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e. deere ave.
santa ana 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key5128338
MDR Text Key27505800
Report Number2025587-2015-01039
Device Sequence Number1
Product Code GKN
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Followup,Followup
Report Date 10/09/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/05/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number305
Device Catalogue Number305
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/09/2015
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age00080 YR
-
-